Daewon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	244,984	305,427	331,930	393,197	342,999	380,715
Market Cap Growth	-20.57%	-7.99%	-15.58%	14.64%	-9.91%	13.65%
Enterprise Value	397,864	434,054	418,509	453,068	412,231	412,859
Last Close Price	11430.00	13957.75	15014.55	17630.58	14913.94	16349.11
PE Ratio	-	21.49	13.88	12.31	49.08	21.58
Forward PE	32.20	9.77	9.77	9.77	9.77	9.77
PS Ratio	0.41	0.51	0.63	0.82	0.97	1.23
PB Ratio	0.93	1.07	1.26	1.58	1.57	1.79
P/TBV Ratio	1.23	1.27	1.37	1.74	1.77	1.88
P/FCF Ratio	14.12	-	8.41	21.36	18.73	27.98
P/OCF Ratio	5.72	10.17	6.42	14.89	15.30	15.26
PEG Ratio	0.82	0.49	0.49	0.49	0.49	0.49
EV/Sales Ratio	0.67	0.73	0.79	0.95	1.16	1.34
EV/EBITDA Ratio	17.07	9.28	8.40	7.28	11.11	10.41
EV/EBIT Ratio	-	16.27	12.98	10.56	21.36	17.22
EV/FCF Ratio	22.93	-	10.61	24.62	22.52	30.35
Debt / Equity Ratio	0.81	0.66	0.55	0.47	0.57	0.25
Debt / EBITDA Ratio	9.67	4.00	2.93	1.87	3.34	1.32
Debt / FCF Ratio	12.30	-	3.70	6.33	6.77	3.86
Net Debt / Equity Ratio	0.55	0.50	0.44	0.28	0.32	0.20
Net Debt / EBITDA Ratio	6.58	3.02	2.33	1.12	1.86	1.06
Net Debt / FCF Ratio	8.37	-29.22	2.94	3.78	3.78	3.08
Asset Turnover	0.98	1.10	1.10	1.09	0.93	0.93
Inventory Turnover	2.97	2.86	2.76	3.01	2.69	2.49
Quick Ratio	0.64	0.62	0.56	0.89	1.07	0.93
Current Ratio	1.12	1.19	1.15	1.62	1.77	2.09
Return on Equity (ROE)	-6.75%	3.68%	9.15%	13.13%	3.07%	8.25%
Return on Assets (ROA)	-0.04%	3.06%	4.19%	6.07%	3.16%	4.52%
Return on Invested Capital (ROIC)	-0.08%	4.14%	8.38%	11.21%	2.75%	7.10%
Return on Capital Employed (ROCE)	-0.10%	7.00%	9.90%	13.20%	5.90%	8.60%
Earnings Yield	-6.55%	4.65%	7.21%	8.12%	2.04%	4.63%
FCF Yield	7.08%	-1.58%	11.88%	4.68%	5.34%	3.57%
Dividend Yield	2.62%	2.15%	-	-	1.30%	0.95%
Payout Ratio	-	44.75%	30.69%	12.90%	44.93%	28.54%
Buyback Yield / Dilution	1.14%	-1.47%	0.98%	-3.09%	0.58%	1.06%
Total Shareholder Return	3.77%	0.68%	0.98%	-3.09%	1.88%	2.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.